BTI
GILD icon

Blue Trust Inc’s Gilead Sciences GILD Stock Holding History

Blue Trust Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$631K Buy
4,996
+141
+3% +$18.6K 0.01% 413
2026
Q1 		$677K Sell
4,855
-178
-4% -$24.9K 0.01% 387
2025
Q4 		$618K Sell
5,033
-607
-11% -$73.8K 0.01% 415
2025
Q3 		$626K Buy
5,640
+1,143
+25% +$130K 0.01% 416
2025
Q2 		$499K Buy
4,497
+499
+12% +$53.1K 0.01% 446
2025
Q1 		$448K Buy
3,998
+472
+13% +$48.7K 0.01% 435
2024
Q4 		$326K Sell
3,526
-2,994
-46% -$270K ﹤0.01% 503
2024
Q3 		$447K Buy
6,520
+1,808
+38% +$138K 0.01% 516
2024
Q2 		$345K Buy
4,712
+3,473
+280% +$232K ﹤0.01% 510
2024
Q1 		$90.7K Sell
1,239
-2,461
-67% -$189K ﹤0.01% 742
2023
Q4 		$276K Buy
3,700
+937
+34% +$72.9K ﹤0.01% 353
2023
Q3 		$213K Buy
2,763
+507
+22% +$39K ﹤0.01% 419
2023
Q2 		$187K Sell
2,256
-1,209
-35% -$96.4K ﹤0.01% 372
2023
Q1 		$298K Buy
3,465
+370
+12% +$30.6K ﹤0.01% 409
2022
Q4 		$191K Buy
3,095
+1,608
+108% +$127K ﹤0.01% 466
2022
Q3 		$92K Buy
1,487
+629
+73% +$39.7K ﹤0.01% 552
2022
Q2 		$51K Buy
+858
New +$53.1K ﹤0.01% 677

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Blue Trust Inc's GILD Position: Q2 2026 in Review

Blue Trust Inc increased its Gilead Sciences (GILD) stake by 2.9% in Q2 2026, buying an estimated $18.6K and bringing the position to 4,996 shares worth $631K. The position accounts for 0.01% of the portfolio, ranked #413.

Blue Trust Inc first reported a position in GILD in Q2 2022 and has held it in 17 quarters since. The position peaked at $677K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Blue Trust Inc held 4,996 shares of Gilead Sciences worth $631K as of Q2 2026.
  • Blue Trust Inc bought 141 Gilead Sciences shares in Q2 2026, an estimated $18.6K.
  • Gilead Sciences made up 0.01% of Blue Trust Inc's portfolio in Q2 2026, its #413 holding.
  • Blue Trust Inc first reported a position in Gilead Sciences in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Gilead Sciences position peaked at $677K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.